Acadia Healthcare (NASDAQ:ACHC) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.
ACHC has been the topic of several other research reports. BMO Capital Markets reaffirmed an “outperform” rating and set a $45.00 target price (up previously from $40.00) on shares of Acadia Healthcare in a research note on Friday, February 23rd. BidaskClub raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, February 2nd. Wells Fargo initiated coverage on shares of Acadia Healthcare in a research report on Tuesday, January 30th. They issued an “outperform” rating and a $41.00 target price on the stock. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, February 12th. Finally, Credit Suisse Group reiterated a “neutral” rating and set a $40.00 price target (up from $35.00) on shares of Acadia Healthcare in a research note on Thursday, February 22nd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $44.50.
Shares of NASDAQ ACHC opened at $39.46 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.25 and a debt-to-equity ratio of 1.25. Acadia Healthcare has a 12 month low of $26.92 and a 12 month high of $54.34. The company has a market cap of $3,483.25, a price-to-earnings ratio of 17.16, a price-to-earnings-growth ratio of 1.29 and a beta of 0.63.
In related news, Director Reeve B. Waud sold 200,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 6th. The stock was sold at an average price of $39.02, for a total transaction of $7,804,000.00. Following the completion of the transaction, the director now owns 10,088 shares in the company, valued at approximately $393,633.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Randall P. Goldberg sold 960 shares of the business’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $38.47, for a total value of $36,931.20. Following the transaction, the vice president now owns 6,942 shares of the company’s stock, valued at approximately $267,058.74. The disclosure for this sale can be found here. Insiders have sold a total of 401,360 shares of company stock worth $15,759,096 over the last 90 days. 11.10% of the stock is owned by company insiders.
Hedge funds have recently made changes to their positions in the business. State of Alaska Department of Revenue acquired a new position in Acadia Healthcare during the 4th quarter worth $150,000. Tyers Asset Management LLC boosted its position in Acadia Healthcare by 31.8% during the 4th quarter. Tyers Asset Management LLC now owns 5,904 shares of the company’s stock worth $193,000 after acquiring an additional 1,424 shares during the period. Xact Kapitalforvaltning AB acquired a new position in Acadia Healthcare during the 4th quarter worth $231,000. CIBC World Markets Inc. acquired a new position in Acadia Healthcare during the 4th quarter worth $236,000. Finally, Arthur Zaske & Associates LLC acquired a new position in Acadia Healthcare during the 3rd quarter worth $283,000.
ILLEGAL ACTIVITY WARNING: “ValuEngine Downgrades Acadia Healthcare (ACHC) to Sell” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3342233/valuengine-downgrades-acadia-healthcare-achc-to-sell.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.